Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 26;13(3):71.
doi: 10.3390/diseases13030071.

Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients

Michał Oleszko  1 , Paweł Zapolnik  1 , Wojciech Kmiecik  2 , Hanna Czajka  1
Affiliations
Review

Herpes Zoster: Risk Factors for Occurrence, Complications, and Recurrence with a Focus on Immunocompromised Patients

Michał Oleszko et al. Diseases. .

Abstract

Background: The varicella-zoster virus is a highly contagious human herpesvirus that primarily causes varicella (chickenpox) as an initial infection, targeting T cells, neurons, as well as skin cells, and can later reactivate to cause herpes zoster (shingles). Following reactivation, the varicella-zoster virus infection can lead to severe complications, the most common of which is postherpetic neuralgia. Risk factors include aging, immunosuppression, chronic diseases such as diabetes, cardiovascular disorders, respiratory conditions, and others.

Objective: In this article, we present an analysis of factors increasing the risk of herpes zoster occurrence, complications, and recurrences (in particular in immunocompromised patients).

Keywords: chickenpox; communicable disease; herpes zoster; immunology; infections.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Rani N.A., Moin A.T., Patil R., Robin T.B., Zubair T., Nawal N., Sami R.S., Morshed M., Zhai J., Xue M., et al. Designing a polyvalent vaccine targeting multiple strains of varicella zoster virus using integrated bioinformatics approaches. Front. Microbiol. 2023;14:1291868. doi: 10.3389/fmicb.2024.1498557. - DOI - PMC - PubMed
    1. Tayyar R., Ho D. Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients. Viruses. 2023;15:439. doi: 10.3390/v15020439. - DOI - PMC - PubMed
    1. Gershon A.A., Breuer J., Cohen J.I., Cohrs R.J., Gershon M.D., Gilden D., Grose C., Hambleton S., Kennedy P.G., Oxman M.N., et al. Varicella zoster virus infection. Nat. Rev. Dis. Primers. 2015;1:15016. doi: 10.1038/nrdp.2015.16. - DOI - PMC - PubMed
    1. Ishihara R., Watanabe R., Shiomi M., Katsushima M., Fukumoto K., Yamada S., Okano T., Hashimoto M. Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine. Biomolecules. 2024;14:739. doi: 10.3390/biom14070739. - DOI - PMC - PubMed
    1. Schaap-Nutt A., Sommer M., Che X., Zerboni L., Arvin A.M. ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo. J. Virol. 2006;80:11806–11816. doi: 10.1128/JVI.00466-06. - DOI - PMC - PubMed

LinkOut - more resources